Nathan Bromham
Research Subjects
Research Interests
Nathan Bromham has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Barry Hancock
University of Sheffield, Weston Park Hospital, Sheffield S10 2SJ, UK
1 shared publicationC. Redman
University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG, UK
1 shared publication- Chi-Ho To
School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China
1 shared publication E Webb
Department of Child Health, University of Wales College of Medicine, Cardiff, UK
1 shared publicationFergus Macbeth
National Collaborating Centre for Cancer, Cardiff CF10 3AF
1 shared publicationFfion M. John
School of Optometry and Vision Sciences, Cardiff University, Cardiff, Wales, United Kingdom
1 shared publication
Latest Publications
- 1 June 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1014) , 661-671
Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines
Carcinoma of unknown primary origin (CUP) accounts for 3-5% of cancer cases and is the fourth most common cause of cancer death in the UK. CUP management is challenging, partly owing to the heterogeneity of the condition and its presentation, but also owing to the lack of dedicated clinical services for these patients. The recent National Institute for Health and Clinical Excellence (NICE) guidelines on metastatic malignancy of unknown primary origin were developed to improve the co-ordination of diagnostic and clinical services at hospitals treating cancer patients in England and Wales, in particular by the setting up of CUP teams to manage these patients. Radiologists have a vital role in the diagnosis of these patients and should work closely with the CUP team to streamline the diagnostic pathway. This article summarises areas of the NICE guidelines relevant to radiology and discusses the radiological management of patients with CUP, including initial investigation, the importance of biopsy, the management of specific presentations, special investigations and organisational issues.
- 1 June 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1014) , 661-671
Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines
Carcinoma of unknown primary origin (CUP) accounts for 3-5% of cancer cases and is the fourth most common cause of cancer death in the UK. CUP management is challenging, partly owing to the heterogeneity of the condition and its presentation, but also owing to the lack of dedicated clinical services for these patients. The recent National Institute for Health and Clinical Excellence (NICE) guidelines on metastatic malignancy of unknown primary origin were developed to improve the co-ordination of diagnostic and clinical services at hospitals treating cancer patients in England and Wales, in particular by the setting up of CUP teams to manage these patients. Radiologists have a vital role in the diagnosis of these patients and should work closely with the CUP team to streamline the diagnostic pathway. This article summarises areas of the NICE guidelines relevant to radiology and discusses the radiological management of patients with CUP, including initial investigation, the importance of biopsy, the management of specific presentations, special investigations and organisational issues.
Cryotherapy and high intensity focused ultrasound for prostate cancer
More evidence is needed before they can be recommended for widespread use Men with prostate cancer and their healthcare professionals are faced with several options for treating the primary tumour at the time of diagnosis and any recurrence. Newer treatments such as cryotherapy and high intensity focused ultrasound are available in some centres in the United Kingdom and have enthusiastic advocates. In 2005, the National Institute for Health and Clinical Excellence (NICE) issued guidance on cryotherapy and ultrasound treatment saying that “the current evidence on efficacy and safety” seemed “adequate to support their use” in patients with prostate cancer.1 2 But in 2008, NICE published clinical guidelines on prostate cancer which stated that these treatments “are not recommended for men with localised prostate cancer other than in the context of controlled clinical trials comparing their use with established interventions.”3 This apparent change of heart caused concern among urologists and even reached the national press.4 However, the advice was not really inconsistent—NICE deemed these techniques safe and efficacious enough to be used but thought that the evidence on their clinical effectiveness compared with alternatives was insufficient to recommend their routine use in the NHS. Cryotherapy is increasingly …
Cryotherapy and high intensity focused ultrasound for prostate cancer
More evidence is needed before they can be recommended for widespread use Men with prostate cancer and their healthcare professionals are faced with several options for treating the primary tumour at the time of diagnosis and any recurrence. Newer treatments such as cryotherapy and high intensity focused ultrasound are available in some centres in the United Kingdom and have enthusiastic advocates. In 2005, the National Institute for Health and Clinical Excellence (NICE) issued guidance on cryotherapy and ultrasound treatment saying that “the current evidence on efficacy and safety” seemed “adequate to support their use” in patients with prostate cancer.1 2 But in 2008, NICE published clinical guidelines on prostate cancer which stated that these treatments “are not recommended for men with localised prostate cancer other than in the context of controlled clinical trials comparing their use with established interventions.”3 This apparent change of heart caused concern among urologists and even reached the national press.4 However, the advice was not really inconsistent—NICE deemed these techniques safe and efficacious enough to be used but thought that the evidence on their clinical effectiveness compared with alternatives was insufficient to recommend their routine use in the NHS. Cryotherapy is increasingly …
- 1 November 2005
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 46 (11) , 4024-31
Anisometropia Is Independently Associated with Both Spherical and Cylindrical Ametropia
To explore the associations between anisometropia and spherical ametropia, astigmatism, age, and sex. Associations between the prevalence and magnitude of anisometropia with age, sex, spherical power, and cylindrical power, were assessed in a group of 90,884 subjects attending optometry practices in the United Kingdom. Logistic regression models were used to assess the independent contribution of each explanatory variable. Logistic regression analyses that included all subjects or just those aged 20 to 40 years showed that spherical ametropia and astigmatism were independently associated with anisometropia (myopes, P < 1.0E-61; hyperopes, P < 1.0E-11). Anisometropia was relatively stable between the ages of 20 and 40 years, but then became more common with age, in myopes from the age of 40 years onward (P < 0.003) and in hyperopes from the age of 70 years onward (P < 1.0E-6). Sex was not associated with anisometropia to a clinically significant extent. This is the first study to show an independent association between anisometropia and both spherical ametropia and astigmatism. The results also suggest that the previously noted increased prevalence of anisometropia with age occurs later in hyperopes than in myopes, once other covariates have been controlled for. However, it could not be ruled out that this latter effect was due to clinical selection bias in our sample. The findings suggest that research projects involving the recruitment of highly ametropic subjects, such as those investigating the genetics of refractive error, may benefit by avoiding the use of stringent inclusion criteria for anisometropia, because otherwise a large proportion of the relevant population will be excluded.
- 1 November 2005
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 46 (11) , 4024-31
Anisometropia Is Independently Associated with Both Spherical and Cylindrical Ametropia
To explore the associations between anisometropia and spherical ametropia, astigmatism, age, and sex. Associations between the prevalence and magnitude of anisometropia with age, sex, spherical power, and cylindrical power, were assessed in a group of 90,884 subjects attending optometry practices in the United Kingdom. Logistic regression models were used to assess the independent contribution of each explanatory variable. Logistic regression analyses that included all subjects or just those aged 20 to 40 years showed that spherical ametropia and astigmatism were independently associated with anisometropia (myopes, P < 1.0E-61; hyperopes, P < 1.0E-11). Anisometropia was relatively stable between the ages of 20 and 40 years, but then became more common with age, in myopes from the age of 40 years onward (P < 0.003) and in hyperopes from the age of 70 years onward (P < 1.0E-6). Sex was not associated with anisometropia to a clinically significant extent. This is the first study to show an independent association between anisometropia and both spherical ametropia and astigmatism. The results also suggest that the previously noted increased prevalence of anisometropia with age occurs later in hyperopes than in myopes, once other covariates have been controlled for. However, it could not be ruled out that this latter effect was due to clinical selection bias in our sample. The findings suggest that research projects involving the recruitment of highly ametropic subjects, such as those investigating the genetics of refractive error, may benefit by avoiding the use of stringent inclusion criteria for anisometropia, because otherwise a large proportion of the relevant population will be excluded.
- 1 May 2004
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 45 (5) , 1566-1572
Spatial Vision Deficits in Infants and Children with Down Syndrome
Purpose. Infants and children with Down syndrome show reduced visual acuity and contrast sensitivity when tested with conventional behavioral techniques. These results may reflect sensory deficits of optical or neural origin or a loss of performance in mechanisms responsible for generating the behavioral response. The purpose of this study was to compare objective acuity and contrast sensitivity measurements recorded with visual-evoked potentials (VEPs), with behavioral clinical test results in a group of children with Down syndrome and a group of control subjects. The goal was to determine whether children with Down syndrome still have a sensory deficit when tested using a procedure that is less cognitively demanding than conventional tests. methods. The subject group comprised 58 children with Down syndrome and 44 control subjects, aged 3 months to 14.15 years. Visual acuity and contrast sensitivity were measured with steady state, swept VEPs and behavioral techniques. VEP acuity was obtained from 36 children with Down syndrome and 40 control subjects, and behavioral acuity from 54 children with Down syndrome and 35 control subjects. VEP contrast sensitivity was measured in 24 children with Down syndrome and 34 control subjects, and behavioral contrast sensitivity in 42 children with Down syndrome and 25 control subjects. Group differences in visual acuity and contrast sensitivity were analyzed with an analysis of covariance (ANCOVA), with age as a covariate. results. Visual acuity thresholds were significantly lower in the group with Down syndrome than in the control group. This was true for both VEP (P < 0.01) and behavioral measures (P < 0.01). The Down syndrome group also had reduced contrast sensitivity when compared with the control subjects, for VEP contrast sensitivity (P < 0.01) and behavioral contrast sensitivity (P < 0.01). The group differences remained when children with ophthalmic anomalies were excluded from the analysis. conclusions. The reduced visual acuity and contrast sensitivity in the Down syndrome group support the idea of an underlying sensory deficit in the visual system in Down syndrome.
- 1 May 2004
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 45 (5) , 1566-1572
Spatial Vision Deficits in Infants and Children with Down Syndrome
Purpose. Infants and children with Down syndrome show reduced visual acuity and contrast sensitivity when tested with conventional behavioral techniques. These results may reflect sensory deficits of optical or neural origin or a loss of performance in mechanisms responsible for generating the behavioral response. The purpose of this study was to compare objective acuity and contrast sensitivity measurements recorded with visual-evoked potentials (VEPs), with behavioral clinical test results in a group of children with Down syndrome and a group of control subjects. The goal was to determine whether children with Down syndrome still have a sensory deficit when tested using a procedure that is less cognitively demanding than conventional tests. methods. The subject group comprised 58 children with Down syndrome and 44 control subjects, aged 3 months to 14.15 years. Visual acuity and contrast sensitivity were measured with steady state, swept VEPs and behavioral techniques. VEP acuity was obtained from 36 children with Down syndrome and 40 control subjects, and behavioral acuity from 54 children with Down syndrome and 35 control subjects. VEP contrast sensitivity was measured in 24 children with Down syndrome and 34 control subjects, and behavioral contrast sensitivity in 42 children with Down syndrome and 25 control subjects. Group differences in visual acuity and contrast sensitivity were analyzed with an analysis of covariance (ANCOVA), with age as a covariate. results. Visual acuity thresholds were significantly lower in the group with Down syndrome than in the control group. This was true for both VEP (P < 0.01) and behavioral measures (P < 0.01). The Down syndrome group also had reduced contrast sensitivity when compared with the control subjects, for VEP contrast sensitivity (P < 0.01) and behavioral contrast sensitivity (P < 0.01). The group differences remained when children with ophthalmic anomalies were excluded from the analysis. conclusions. The reduced visual acuity and contrast sensitivity in the Down syndrome group support the idea of an underlying sensory deficit in the visual system in Down syndrome.
- 1 March 2003
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 44 (3) , 1023-1030
Development of Refractive Error and Strabismus in Children with Down Syndrome
Purpose. To investigate the development of refractive errors and strabismus in a cohort of children with Down syndrome. method. Data for 55 children with Down syndrome who are participating in this longitudinal study of visual development, first examined by us when aged less than 2 years and on at least two other occasions, were analyzed. Mohindra retinoscopy was used to measure refractive error. Ocular alignment was assessed using the Hirschberg test and, when possible, the cover test. results. Despite the high prevalence of large refractive errors in children with Down syndrome, longitudinal data showed that these are not always present in early infancy. Twenty-one (38%) of the children were emmetropic throughout the study. Of the 24 children with a significant refractive error at the outset, only 6 (25%) showed emmetropization. The others retained or increased their refractive errors. The remaining 10 children were emmetropic at the outset, but then had a significant refractive error develop. There is a high prevalence of strabismus in children with Down syndrome (29% of the total group), which cannot be attributed to the presence of hypermetropia or anisometropia. conclusions. The retention or development of infantile refractive errors in many children with Down syndrome indicates a failure of emmetropization. All children were at risk of strabismus whatever the refractive error. The findings have implications for timing of screening programs.
- 1 March 2003
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 44 (3) , 1023-1030
Development of Refractive Error and Strabismus in Children with Down Syndrome
Purpose. To investigate the development of refractive errors and strabismus in a cohort of children with Down syndrome. method. Data for 55 children with Down syndrome who are participating in this longitudinal study of visual development, first examined by us when aged less than 2 years and on at least two other occasions, were analyzed. Mohindra retinoscopy was used to measure refractive error. Ocular alignment was assessed using the Hirschberg test and, when possible, the cover test. results. Despite the high prevalence of large refractive errors in children with Down syndrome, longitudinal data showed that these are not always present in early infancy. Twenty-one (38%) of the children were emmetropic throughout the study. Of the 24 children with a significant refractive error at the outset, only 6 (25%) showed emmetropization. The others retained or increased their refractive errors. The remaining 10 children were emmetropic at the outset, but then had a significant refractive error develop. There is a high prevalence of strabismus in children with Down syndrome (29% of the total group), which cannot be attributed to the presence of hypermetropia or anisometropia. conclusions. The retention or development of infantile refractive errors in many children with Down syndrome indicates a failure of emmetropization. All children were at risk of strabismus whatever the refractive error. The findings have implications for timing of screening programs.
- Open Access
- 1 December 2002
- Published by BMJ in British Journal of Ophthalmology
- Vol. 86 (12) , 1367-1368
Heart defects and ocular anomalies in children with Down's syndrome
Aims: To investigate whether ocular anomalies are associated with congenital heart defects in children with Down’s syndrome. Methods: 58 children with Down’s syndrome were entered into a retrospective observational study. Children were assigned to heart defect groups based on medical records. Optometric tests had previously been carried out at the homes of the children. Results: A relation between congenital cardiac defects, myopia, and nystagmus was observed. Heart problems were not related to accommodative insufficiency, hyperopia, or strabismus. Conclusion: In children with Down’s syndrome heart defects were associated with both myopia and nystagmus.
- 1 December 2002
- Published by BMJ in British Journal of Ophthalmology
- Vol. 86 (12) , 1367-1368
Open AccessHeart defects and ocular anomalies in children with Down's syndrome
Aims: To investigate whether ocular anomalies are associated with congenital heart defects in children with Down’s syndrome. Methods: 58 children with Down’s syndrome were entered into a retrospective observational study. Children were assigned to heart defect groups based on medical records. Optometric tests had previously been carried out at the homes of the children. Results: A relation between congenital cardiac defects, myopia, and nystagmus was observed. Heart problems were not related to accommodative insufficiency, hyperopia, or strabismus. Conclusion: In children with Down’s syndrome heart defects were associated with both myopia and nystagmus.